Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ELEPHANT trial of DS-3201b in pediatric, adolescent, and young adult malignant solid tumors
jRCT2031190268Phase 1Completed
- Sponsor
- Japan Agency for Medical Research and Development
- Start
- Mar 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label trial of valemetostat in Non-hematologic malignancy (2 arms), sponsored by Japan Agency for Medical Research and Development. Primary endpoint: Rate of dose-limiting toxicity. Started Mar 2020; status: completed.
02
Drugs
valemetostat
03
Conditions
Non-hematologic malignancy
Beyond the preview
Go deeper on jRCT2031190268.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2031190268.